With 0.33 million shares changed hands, the volume of the stock remained lighter than its average volume of 0.95 million shares. During the session, the Drug Manufacturers – Specialty & Generic company that operates in wider Healthcare sector, reached to the highest price of $9.33 whereas the lowest price it dropped to was $9.08. The 52-week range on INDV shows that it touched its highest point at $23.22 and its lowest point at $7.33 during that stretch. It currently has a 1-year price target of $17.51. Beta for the stock currently stands at 0.78.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of INDV was up-trending over the past week, with a rise of 2.91%, but this was down by -11.90% over a month. Three-month performance dropped to -32.10% while six-month performance fell -49.42%. The stock lost -53.73% in the past year, while it has lost -39.88% so far this year. A look at the trailing 12-month EPS for INDV yields -0.04 with Next year EPS estimates of 1.66. For the next quarter, that number is 0.26. This implies an EPS growth rate of 8.54% for this year and -2.41% for next year. EPS is expected to grow by 2.51% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of -62.20%.
Float and Shares Shorts:
At present, 136.53 million INDV shares are outstanding with a float of 127.60 million shares on hand for trading. On 2024-10-15, short shares totaled 0.8 million, which was 77.0 higher than short shares on 1726185600. In addition to Mr. Mark Crossley as the firm’s CEO & Executive Director, Mr. Ryan Preblick serves as its CFO & Executive Director.
Institutional Ownership:
Through their ownership of 0.87503 of INDV’s outstanding shares, institutional investors have minority control over the company.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2024-09-30, INDV reported revenue of $307000000.0 and operating income of $4000000.0. The EBITDA in the recently reported quarter was $9000000.0 and diluted EPS was $0.03.
